Fei Huang

机构：Gilead Sciences (United States) · ORCID：0000-0003-3263-0675

发表论文 192 篇 · 总被引 4810 次 · h-index 37

代表论文

• Imetelstat, a novel, first‐in‐class telomerase inhibitor: Mechanism of action, clinical, and translational science (2024 · Clinical and Translational Science · 被引 30)
• Forebrain neural progenitors effectively integrate into host brain circuits and improve neural function after ischemic stroke (2025 · Nature Communications · 被引 19)
• The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation (2024 · Nature Communications · 被引 18)
• m6A-dependent mature miR-151-5p accelerates the malignant process of HNSCC by targeting LYPD3 (2024 · Molecular Biomedicine · 被引 14)
• Apelin regulates mitochondrial dynamics by inhibiting Mst1-JNK-Drp1 signaling pathway to reduce neuronal apoptosis after spinal cord injury (2024 · Neurochemistry International · 被引 13)
• An injectable responsive exosome-releasing hydrogel based on sodium alginate restores motor and bladder function by alleviating the injury microenvironment and facilitating distal nerve repair (2025 · International Journal of Biological Macromolecules · 被引 12)